Shares of Emcure Pharma surges over 31 percent in debut trade
Advertisement
New Delhi: Shares of Emcure Pharmaceuticals Ltd made a debut on Wednesday as they listed with a significant premium of over 31 percent against their issue price of Rs 1,008.
The stock opened trading at Rs 1,325.05, up 31.45 per cent on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), marking a strong initial surge.
Later, the company's stock zoomed 37.30 per cent to Rs 1,384 on BSE and 37.40 per cent to Rs 1,385 on NSE.
Read also: Emcure Pharma set to launch IPO on July 3
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.